[EN] ISOTOPOLOGUES OF ISOQUINOLINONE AND QUINAZOLINONE COMPOUNDS AND USES THEREOF AS PI3K KINASE INHIBITORS [FR] ISOTOPOLOGUES DE COMPOSÉS ISOQUINOLINONE ET QUINAZOLINONE ET LEURS UTILISATIONS COMME INHIBITEURS DE LA KINASE PI3K
[EN] ISOTOPOLOGUES OF ISOQUINOLINONE AND QUINAZOLINONE COMPOUNDS AND USES THEREOF AS PI3K KINASE INHIBITORS [FR] ISOTOPOLOGUES DE COMPOSÉS ISOQUINOLINONE ET QUINAZOLINONE ET LEURS UTILISATIONS COMME INHIBITEURS DE LA KINASE PI3K
[EN] CONDENSED IMIDAZOLE DERIVATIVES SUBSTITUTED BY TERTIARY HYDROXY GROUPS AS PI3K-GAMMA INHIBITORS<br/>[FR] DÉRIVÉS D'IMIDAZOLE CONDENSÉS, SUBSTITUÉS PAR DES GROUPES HYDROXY TERTIAIRES, UTILISÉS COMME INHIBITEURS DE PI3K-GAMMA
申请人:INCYTE CORP
公开号:WO2019079469A1
公开(公告)日:2019-04-25
This application relates to compounds of Formula (I): or pharmaceutically acceptable salts thereof, which are inhibitors of PI3K-y which are useful for the treatment of disorders such as autoimmune diseases, cancer, cardiovascular diseases, and neurodegenerative diseases.
The present invention provides a compound of Formula (I) or a salt thereof;
and therapeutic uses of these compounds. The present invention further provides pharmaceutical compositions comprising these compounds, and compositions comprising these compounds with a therapeutic co-agent.
[EN] 1-METHYLPYRAZOLE MODULATORS OF SUBSTANCE P, CALCITONIN GENE-RELATED PEPTIDE, ADRENERGIC RECEPTOR, AND/OR 5-HT RECEPTOR<br/>[FR] MODULATEURS 1-MÉTHYLPYRAZOLE DE LA SUBSTANCE P, DU PEPTIDE APPARENTÉ AU GÈNE DE LA CALCITONINE, DES RÉCEPTEURS ADRÉNERGIQUES ET/OU DES RÉCEPTEURS 5-HT
申请人:AUSPEX PHARMACEUTICALS INC
公开号:WO2010123999A3
公开(公告)日:2011-02-24
Fvp of bis- and tris-(pyrazol-1-yl)methane. A radical reaction
作者:Jorge D. Pérez、Gloria I. Yranzo、Marisa A. Ferraris、Rosa M.XXX Claramunt、Concepción López、José Elguero
DOI:10.1016/s0040-4020(01)89830-6
日期:——
[EN] ISOTOPOLOGUES OF ISOQUINOLINONE AND QUINAZOLINONE COMPOUNDS AND USES THEREOF AS PI3K KINASE INHIBITORS<br/>[FR] ISOTOPOLOGUES DE COMPOSÉS ISOQUINOLINONE ET QUINAZOLINONE ET LEURS UTILISATIONS COMME INHIBITEURS DE LA KINASE PI3K
申请人:INFINITY PHARMACEUTICALS INC
公开号:WO2017161116A1
公开(公告)日:2017-09-21
Provided are isotopologues of isoquinolinone and quinazolinone compounds of formula (ΑΒ') that modulate PI3 kinase activity, processes for the preparation of the compounds, pharmaceutical compositions comprising the compounds, and methods of treatment of diseases and disorders using the compounds or pharmaceutical compositions.